SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2936VRTX -21% at low, closed -16% on news: Message 28235649tnsaf-6/29/2012
2935Just sat there like a stuck pig after the news came out, plenty of bids near thescaram(o)uche-6/28/2012
2934SNTA off 24% on interim data for ganetsepib in NSCLC for two reasons I can see: tuck-6/28/2012
2933I understand that. I expect the market to wash out this fall, say by a couple otuck-6/24/2012
2932<i>> I might add this fall, as I feel that eventually MNTA will get FDADewDiligence_on_SI-6/23/2012
2931MNTA off ~20% AH to the low $13s after Teva wins the lower court battle over thetuck-6/23/2012
2930Infinity (INFI), which got almost to $14/share, gives back 15% premarket, as leatuck-6/18/2012
2929ARNA down a bit over 15% in AH since yesterday's close. Probably based onIan@SI-5/15/2012
2928DVAX, on criminal pricing of offering. (Needless to say I own some.)tom pope-5/9/2012
2927Dendreon (DNDN) off 22% on sub-par earnings and margins. Cheers, Tucktuck-5/8/2012
2926Tuck, Still my largest gainer in Charity contest despite the fall today. Of coRobohogs-4/27/2012
2925Pozen (POZN) off about 19% as FDA decides more different doses of its omeprazoletuck-4/27/2012
2924Not bio but wow - check out MDRX. 40+% at worst. JonRobohogs-4/27/2012
2923ITMN down 15% Missed rev and eps. Patient adds were good but lots of them wereIRWIN JAMES FRANKEL-4/27/2012
2922Arena (ARNA) off 19% as Feuerstein defends his position that lorcaserin will nottuck14/18/2012
2921FDA wants more info for their HyQ BLA, regarding chronic use. Partner Baxter istuck-4/16/2012
2920HALO down about 23%. Haven't seen why.Chris08-4/16/2012
2919Optimer down about 12% over problems with Taiwanese affiliate, etc.Chris08-4/10/2012
2918ViroPharma off over 18% as two generic vancocin's finally make it to market,tuck-4/10/2012
2917Also expected to be delayed until 4thQ: sales in EU, per their CC after hours Thtuck-4/9/2012
2916>> So, IJF, I have re-entered the stock ! :-) So did I. I dumped it iIRWIN JAMES FRANKEL-4/9/2012
2915Tuck, ITMN reported on Thurs that their ongoing Ph3 trial in the US with pirfendBiotech Jim-4/9/2012
2914InterMune (ITMN) off 15% on a downgrade by RBC. Not following it, perhaps they tuck-4/9/2012
2913Dara (DARA) off almost 28% on financing with very dilutive terms. Cheers, Tucktuck-4/9/2012
2912FCSC—make that down 63% today and down 91% since FDA approval in Jun 2011.DewDiligence_on_SI-4/2/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):